MedPath

Clinical benefit of measurement of advanced glycogen endproduct level in type 2 diabetes

Not Applicable
Recruiting
Conditions
Type 2 Diabetes
Registration Number
JPRN-UMIN000015966
Lead Sponsor
Human Ethics Review Committee of Kumamoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with infectious disease 2. Patients with acute/chronic inflammatory disease 3. Patients with cancer 4. Patients with acute cerebrovascular disease 5. Patients with severe hepatic disease 6. Patients with severe respiratory 7. Patients with mental disorder 8. Patients decided from attended doctors not to be recruited in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath